High-dose therapy and autologous stem cell transplantation (ASCT) for poor-risk and relapsed non-Hodgkin's lymphoma (NHL): Long-term follow-up results and analysis of prognostic factors in 369 patients.

被引：0
|
作者：
Nademanee, A [1 ]
Molina, A [1 ]
Dagis, AC [1 ]
O'Donnell, MR [1 ]
Snyder, DS [1 ]
Stein, A [1 ]
Parker, PH [1 ]
Wong, KK [1 ]
Kashyap, A [1 ]
Spielberger, RS [1 ]
Fung, HC [1 ]
Krishnan, A [1 ]
Bhatia, R [1 ]
Rodriquez, R [1 ]
Vora, N [1 ]
Sniecinski, I [1 ]
Niland, JC [1 ]
Forman, SJ [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
743
引用
收藏
页码：170A / 170A
页数：1
相关论文
共 50 条
  • [21] High dose therapy with autologous stem cell transplant (ASCT) for non-Hodgkin's lymphoma (NHL) in elderly patients. A single institution retrospective study.
    Buadi, FK
    Micallef, IN
    Ansell, SM
    Porrata, LF
    Inwards, DJ
    BLOOD, 2003, 102 (11) : 736A - 737A
  • [22] High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era
    Ban-Hoefen, Makiko
    Friedberg, Jonathan W.
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane L.
    Young, Faith
    Fisher, Richard I.
    Constine, Louis
    Becker, Michael
    Phillips, Gordon L., II
    BLOOD, 2010, 116 (21) : 992 - 992
  • [23] Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
    Nieto, Yago
    Popat, Uday
    Anderlini, Paolo
    Valdez, Ben
    Andersson, Borje
    Liu, Ping
    Hosing, Chitra
    Shpall, Elizabeth J.
    Alousi, Amin
    Kebriaei, Partow
    Qazilbash, Muzaffar
    Parmar, Simrit
    Bashir, Qaiser
    Shah, Nina
    Khouri, Issa
    Rondon, Gabriela
    Champlin, Richard
    Jones, Roy B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (03) : 410 - 417
  • [24] Long term results of radioimmunotherapy with Bexxar/BEAM and autologous stem cell transplantation (ASCT) for chemotherapy resistant aggressive non-Hodgkin's lymphoma (NHL).
    Vose, JM
    Bierman, PJ
    Lynch, JC
    Bociek, GR
    Jacobs, C
    Armitage, JO
    BLOOD, 2003, 102 (11) : 248A - 248A
  • [25] Prognostic factors for patients with non-Hodgkin's lymphoma who underwent high-dose chemotherapy followed by autologous stem cell transplantation
    Kim, YK
    Lee, JJ
    Yang, DH
    Lee, NS
    Won, JH
    Hong, DS
    Park, HS
    Kim, DH
    Kim, JG
    Sohn, SK
    Kim, HJ
    BONE MARROW TRANSPLANTATION, 2005, 35 : S246 - S246
  • [26] High-dose therapy with autologous stem-cell transplantation in aggressive non-Hodgkin's lymphoma
    Verdonck, LF
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 3003 - 3003
  • [27] AUTOLOGOUS STEM CELL TRANSPLANTATION WITH HIGH-DOSE MITOXANTRONE AND MELPHALAN IN PATIENTS WITH HODGKIN AND NON-HODGKIN LYMPHOMA: LONG-TERM SURVIVAL AND TOXICITY DATA
    Gungor, B.
    Yeral, M.
    Adam, M.
    Unsal, C.
    Boga, C.
    Ozdogu, H.
    Koc, Y.
    HAEMATOLOGICA, 2015, 100 : 280 - 280
  • [28] High-dose Chemotherapy (HDC) with rituximab and autologous stem cell support in patients with poor prognosis non-Hodgkin's lymphoma (NHL)
    Ptushkin, V
    Mheidze, D
    Larionova, V
    Zukov, N
    Andreeva, L
    Osmanov, E
    Chimishkyan, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S95 - S95
  • [29] Long-term outcomes of high-dose etoposide and melphalan chemotherapy and autologous stem cell transplantation for non-Hodgkin lymphoma
    Kuruvilla, J.
    Zadeh, S.
    Franke, N.
    Nagy, T.
    Saragosa, R.
    Crump, M.
    Keating, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S148 - S149
  • [30] GEMCITABINE, BUSULFAN AND MELPHALAN (Gem/Bu/Mel) IS A NEW HIGH-DOSE CHEMOTHERAPY (HDC) REGIMEN WITH HIGH ACTIVITY IN REFRACTORY OR POOR-RISK RELAPSED NON-HODGKIN'S LYMPHOMA (NHL) PATIENTS RECEIVING AN AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT)
    Nieto, Y.
    Jones, R. B.
    Popat, U.
    Andersson, B.
    Valdez, B.
    Thall, P.
    Shpall, E. J.
    Chancoco, C.
    Alousi, A.
    Anderlini, P.
    Hosing, C.
    Qazilbash, M.
    Bashir, Q.
    Kebriaei, P.
    Khoui, I
    Ciurea, S.
    Parmar, S.
    Rondon, G.
    Champlin, R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S206 - S206
12345